Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Extended Analysis of HIV Infection in Cisgender Men and Transgender Women Who Have Sex with Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083

UNC Libraries(2023)10.17615/tc7d-x473Source: DataRank Database

Extended Analysis of HIV Infection in Cisgender Men and Transgender Women Who Have Sex with Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083 is a research paper published in UNC Libraries (2023). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.00)OA: greenTopics (52)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (29)

R. Kofron,Kenneth H. Mayer ORCID,M. McCauley,Lei Weng,L.R. Bushman

Live enrichment

PubMed:21097893 OpenAlex:https://openalex.org/W4400021772

National Institutes of Health

Grant: 5UM1AI068613-16

LC: HIV PREVENTION TRIALS NETWORK

National Institutes of Health

Grant: 3UM1AI068617-20S1

HPTN SDMC: HPTN 096 Getting to Zero among Highest HIV Incidence (HHI) Men who have Sex with Men (MSM) in the American South: Testing an Integrated Strategy

National Institutes of Health

Grant: 5UM1AI068619-09

LOC: HIV Prevention Trials Network

FWCI

0.00

Citation Percentile

0.3%

greenLicense: CC BY

repositoryhttps://doi.org/10.17615/tc7d-x473

https://doi.org/10.1128/aac.00053-23

https://dx.doi.org/10.17615/tc7d-x473

https://pubmed.ncbi.nlm.nih.gov/36995219

http://dx.doi.org/10.1128/aac.00053-23

Fields of Study

HIV/AIDS Research and InterventionsHIV Research and TreatmentHIV-related health complications and treatments03 medical and health sciences0303 health sciences

Keywords

Human immunodeficiency virus (HIV)Men who have sex with menTransgender womenMedicineSex partnersGynecologyVirologySyphilisMaleTDF-FTCAnti-HIV AgentsPyridonesClinical Sciencespreexposure prophylaxis610HIV InfectionsSexual and Gender Minorities (SGM/LGBT*)DiketopiperazinesMicrobiologyAntiviral AgentsTransgender PersonspreventionInternal MedicineMedical SpecialtiesMedicine and Health SciencesHumansEmtricitabineTenofovirRetrospective StudiesinjectableBiomedical and Clinical SciencescabotegravirHIVlong-actingPharmacology and Pharmaceutical SciencesMedical microbiology543Health DisparitiesInfectious DiseasesGood Health and Well Being6.1 PharmaceuticalsSexually Transmitted InfectionsHIV/AIDSFemalePre-Exposure ProphylaxisInfectionHPTN 083

Sustainable Development Goals

SDG 0: Gender equality